CBRS Ceo on Cnbc
CBRS Ceo on Cnbc
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Netflix, AbbVie, Cerebras Systems And An Energy Stock On CNBC’s ‘Final Trades’
On CNBC’s “ Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he likes AbbVie Inc. (NYSE: ABBV ). Supporting his choice, Canaccord Genuity analyst Gary Nachman maintained AbbVie with a Buy rating on Wednesday and raised the price target from $273 to $282.
CBRS CEO on CNBC
CBRS CEO is appearing on CNBC